Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Rheum Dis ; 67(11): 1603-9, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18203760

ABSTRACT

CTLA-4 is a regulator of co-stimulation and inhibits the activation of T cells through interfering with the interaction of CD80/86 on antigen-presenting cells with CD28 on T cells. CTLA-4 binds to the surface of antigen-presenting cells, such as dendritic cells and monocytes through CD80/86. Monocytes can differentiate in osteoclasts, the primary bone resorbing cells. Herein, we investigated whether the binding of CTLA-4 affects the differentiation of monocytes into osteoclasts in vitro and vivo. We show that CTLA-4 dose-dependently inhibits RANKL- as well as tumour necrosis factor (TNF)-mediated osteoclastogenesis in vitro without the presence of T cells. Furthermore, CTLA-4 was effective in inhibiting TNF-induced osteoclast formation in a non-T cell dependent TNF-induced model of arthritis as well as the formation of inflammatory bone erosion in vivo. These data suggest that CTLA-4 is an anti-osteoclastogenic molecule that directly binds osteoclast precursor cells and inhibits their differentiation. These findings are an attractive explanation for the anti-erosive effect of abatacept, a CTLA-4 immunoglobulin fusion protein used for the treatment of rheumatoid arthritis.


Subject(s)
Antigens, CD/pharmacology , Osteoclasts/drug effects , Animals , Antigens, CD/metabolism , Antigens, CD/therapeutic use , Arthritis, Experimental/immunology , Arthritis, Experimental/pathology , Arthritis, Experimental/prevention & control , Bone Resorption/immunology , Bone Resorption/pathology , CTLA-4 Antigen , Cell Differentiation/drug effects , Cells, Cultured , Dose-Response Relationship, Immunologic , Humans , Mice , Mice, Transgenic , Monocytes/cytology , Monocytes/drug effects , Monocytes/immunology , Osteoclasts/immunology , Tumor Necrosis Factor-alpha/physiology
2.
Ann Rheum Dis ; 67(5): 602-8, 2008 May.
Article in English | MEDLINE | ID: mdl-17704065

ABSTRACT

OBJECTIVE: Crescentic glomerulonephritis (crGN) is a frequent and life-threatening manifestation of antineutrophil cytoplasmatic antibody-associated vasculitis. Up-regulation of proinflammatory cytokines contributes to renal damage by activation of p38 mitogen-activated protein kinases (MAPKs). However, it is unclear which of the four p38MAPK isoforms are expressed, activated and hence of major importance in crGN. METHODS: Kidney biopsies of patients with antineutrophil cytoplasmatic antibody-positive crGN and control samples were investigated for the expression and phosphorylation of p38MAPK isoforms and downstream target kinase MAPKAP2 by immunohistochemistry. Expression and functional activation of p38MAPK isoforms by TNF was also assessed in a human podocyte cell line by reverse transcription-polymerase chain reaction, immunoblotting and kinase array. RESULTS: Strong expression of p38MAPKalpha, beta and gamma isoforms was found in glomerular podocytes and crescents. Infiltrating leucocytes showed predominant p38MAPKalpha expression. Activation of p38MAPK and its downstream mediator MAPKAP2 was found in crGN confined to glomerular podocytes, crescents and inflammatory infiltrates. Interestingly, corticosteroid treatment before kidney biopsy diminished p38MAPK activation in crGN. Activated p38MAPK co-localised with alpha, beta and gamma isoforms in podocytes and crescents, while leucocytes showed mainly p38MAPKalpha activation. In a human podocyte cell line mRNA and protein of all four p38MAPK isoforms was expressed but only p38MAPKalpha was activated upon challenge with TNF. CONCLUSIONS: This study shows selective p38MAPK isoform expression and activation in crGN. Podocytes and podocyte-induce crescent formation is the main source of p38MAPK activation in crGN. TNF is a potent and selective activator of the alpha-isoform in podocytes, which therefore appears as a main contributor to proinflammatory signalling in the glomerulum of crGN.


Subject(s)
Glomerulonephritis, Membranoproliferative/enzymology , Kidney Glomerulus/enzymology , p38 Mitogen-Activated Protein Kinases/analysis , Antibodies, Antineutrophil Cytoplasmic/immunology , Biopsy , Blotting, Western/methods , Case-Control Studies , Cells, Cultured , Enzyme Activation , Glomerulonephritis, Membranoproliferative/immunology , Granulomatosis with Polyangiitis/immunology , Granulomatosis with Polyangiitis/metabolism , Humans , Immunohistochemistry , Isoenzymes/analysis , Isoenzymes/metabolism , Leukocytes/enzymology , Macrophages/enzymology , Mitogen-Activated Protein Kinase 14/analysis , Mitogen-Activated Protein Kinase 14/metabolism , Phosphorylation , Podocytes/enzymology , Reverse Transcriptase Polymerase Chain Reaction , Statistics, Nonparametric , Tumor Necrosis Factor-alpha/pharmacology , p38 Mitogen-Activated Protein Kinases/metabolism
3.
Arzneimittelforschung ; 40(1): 13-8, 1990 Jan.
Article in English | MEDLINE | ID: mdl-2339994

ABSTRACT

Several hybrid molecules have been synthesized which contain both the 1,4:3,6-dianhydro-hexitol (isohexide) and glycerol partial structures, with nitrate ester groups at different positions. Alkylation of the isohexide ring system with suitable 3-carbon units generates compounds with the 2,3-epoxypropyl side chain as key intermediates. Ring opening of these oxiranes under various conditions yield primary and secondary nitrates as well as dinitrates. Pharmacological screening shows that the new structures are much less active than the parent compounds.


Subject(s)
Cardiotonic Agents/chemical synthesis , Nitrates/chemical synthesis , Sugar Alcohols/chemical synthesis , Chemical Phenomena , Chemistry , Electrocardiography , Nitrates/pharmacology , Stereoisomerism , Structure-Activity Relationship , Sugar Alcohols/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...